GenAI-Powered Insights: Structuring Data and Enhancing Clinical Trials

26

November

  • 3PM London | 4pm German time
  • Free

Why attend?

Join us for an engaging session on “GenAI-Powered Insights: Structuring Data and Enhancing Clinical Trials,” where industry experts will delve into the latest advancements in AI-driven technologies for healthcare research.

Dragan Mileski will explore how GenAI can turn unstructured data from clinical notes, patient feedback, and external databases into actionable insights. He will guide you through the challenges of managing unstructured data in real-world evidence (RWE) studies and demonstrate how GenAI can automatically categorize and summarize this data, improving drug safety and monitoring effectiveness. Dragan will also share best practices and strategic considerations for successfully implementing GenAI into your data management workflows.

Alexandros Sagkriotis will showcase the practical applications of AI in healthcare. Drawing on his experience, he will discuss using natural language processing (NLP) for social media analysis and literature extraction, decoding congress discussions, and employing machine learning (ML) to bridge the gap between RWE and randomized controlled trials (RCTs). Alexandros will also cover how ML can inform the study design of clinical programs, offering actionable strategies to enhance research outcomes.

Don’t miss this opportunity to learn how AI is transforming the landscape of clinical trials and healthcare research!

Speakers

Select a speaker to learn more

Back
Dragan Mileski
CTO and Co-Founder of Climedo

Dragan is an IT specialist with a strong entrepreneurial drive. In 2017 he dedicated himself to a mission to help patients get the best possible medical treatment through intelligent software solutions. As a result he co-founded Climedo Health where he took the role of Chief Technology Officer (CTO). At Climedo, Dragan leads dedicated product and tech teams focused on developing top-notch software solutions. These solutions aim to transform post-market #RWE studies by providing better real-time transparency of outcomes and enhancing engagement with healthcare professionals throughout the process.

Next speaker
Back
Alexandros Sagkriotis
Real World Evidence

Alexandros Sagkriotis is Head of Evidence & Communications at LEO Pharma, where he oversees real world evidence strategy and real-world data transformation initiatives. With a career spanning over 30 years in the pharmaceutical industry, Alexandros has successfully led numerous high-impact projects.

He holds a BSc in Mathematics from the National & Kapodistrian University of Athens and two MSc in Biometrics from the University of Reading and International HTA, Pricing and Reimbursement from the University of Sheffield.

Outside of work, Alexandros is passionate about visiting new places and meeting new cultures, attending art events, and following a healthy lifestyle.

Next speaker

Enquiry